To accelerate the development of safe, personalized and effective therapies, we place the patient at the center of the preclinical development process. We do this by fully utilizing the power of three innovation platforms – Artificial Intelligence being one of them.

The AI platform will develop, train, and verify AI tools which will be implemented throughout the preclinical development process. Applying these tools on clinically relevant datasets will help us to identify and optimize therapies, predict their efficacy and safety, and pinpoint potential patients for proof-of-concept studies. In this video, platform lead Gerard van Westen explains more about what the AI platform entails in practice.